{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:37:35Z","timestamp":1791549455499,"version":"4.3.4"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.drudis.2022.103393","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:12:35Z","timestamp":1664971955000},"page":"103393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes"],"prefix":"10.1016","volume":"28","author":[{"given":"Huiwen","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2104-534X","authenticated-orcid":false,"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity Y.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.103393_b0005","doi-asserted-by":"crossref","first-page":"e2100275","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.drudis.2022.103393_b0010","first-page":"384","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"127","author":"Schleicher","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.drudis.2022.103393_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.drudis.2022.103393_b0020","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.103393_b0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.08.042","article-title":"Preparation, properties and challenges of the microneedles-based insulin delivery system","volume":"288","author":"Chen","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2022.103393_b0030","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3390\/cells10082160","article-title":"The interactions of insulin and vitamin A signaling systems for the regulation of hepatic glucose and lipid metabolism","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2022.103393_b0035","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-56-6-1294","article-title":"Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion","volume":"56","author":"Eaton","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.drudis.2022.103393_b0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diab.33.5.486","article-title":"C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations","volume":"33","author":"Polonsky","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2022.103393_b0045","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/db11-1462","article-title":"Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling","volume":"61","author":"Matveyenko","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2022.103393_b0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s001250051474","article-title":"Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?","volume":"43","author":"Bergman","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2022.103393_b0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI27073","article-title":"Insulin\u2019s direct effects on the liver dominate the control of hepatic glucose production","volume":"116","author":"Edgerton","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2022.103393_b0060","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00125-021-05417-3","article-title":"Celebrating 100 years of insulin","volume":"64","author":"Marshall","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2022.103393_b0065","doi-asserted-by":"crossref","first-page":"1910168","DOI":"10.1002\/adfm.201910168","article-title":"Liver-target and glucose-responsive polymersomes toward mimicking endogenous insulin secretion with improved hepatic glucose utilization","volume":"30","author":"Wang","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.drudis.2022.103393_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.drudis.2022.103393_b0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/ph13100307","article-title":"Recent progress of chitosan and chitosan derivatives-based nanoparticles: pharmaceutical perspectives of oral insulin delivery","volume":"13","author":"Seyam","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.drudis.2022.103393_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1758-5996-2-66","article-title":"Oral insulin","volume":"2","author":"Kalra","year":"2010","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.drudis.2022.103393_b0085","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/ijms23063362","article-title":"Versatile oral insulin delivery nanosystems: from materials to nanostructures","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.drudis.2022.103393_b0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.tips.2021.08.005","article-title":"Nanocarriers for oral delivery of biologics: small carriers for big payloads","volume":"42","author":"Cao","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jddst.2017.06.018","article-title":"Advances on the formulation of proteins using nanotechnologies","volume":"42","author":"Santalices","year":"2017","journal-title":"J Drug Deliv Sci Tec"},{"key":"10.1016\/j.drudis.2022.103393_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104685","article-title":"Oral administration of protein nanoparticles: An emerging route to disease treatment","volume":"158","author":"Sadeghi","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2022.103393_b0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/pharmaceutics13071042","article-title":"PLGA-based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases","volume":"13","author":"Cunha","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2022.103393_b0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/nano12030354","article-title":"Recent advances in the surface functionalization of PLGA-based nanomedicines","volume":"12","author":"El-Hammadi","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.drudis.2022.103393_b0120","doi-asserted-by":"crossref","DOI":"10.1088\/2053-1591\/ac3f5e","article-title":"PLGA-based drug delivery system for combined therapy of cancer: research progress","volume":"8","author":"Ruirui","year":"2021","journal-title":"Mater Res Express"},{"key":"10.1016\/j.drudis.2022.103393_b0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloid Surface B"},{"key":"10.1016\/j.drudis.2022.103393_b0130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3390\/pharmaceutics13091505","article-title":"Optimisation of a microfluidic method for the delivery of a small peptide","volume":"13","author":"Han","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2022.103393_b0135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2022.103393_b0140","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.biomaterials.2009.01.057","article-title":"The uptake and intracellular fate of PLGA nanoparticles in epithelial cells","volume":"30","author":"Cartiera","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2022.103393_b0145","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/jbm.a.35498","article-title":"Cytotoxicity and intracellular fate of PLGA and chitosan-coated PLGA nanoparticles in Madin-Darby bovine kidney (MDBK) and human colorectal adenocarcinoma (Colo 205) cells","volume":"103","author":"Trif","year":"2015","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.drudis.2022.103393_b0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0155","first-page":"297","article-title":"Novel technique of insulin loading into porous carriers for oral delivery","volume":"13","author":"Eilleia","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.drudis.2022.103393_b0165","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1021\/mp500439c","article-title":"Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge","volume":"11","author":"Bannunah","year":"2014","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.drudis.2022.103393_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.045","article-title":"Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery","volume":"342","author":"Xi","year":"2022","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2021.11.020","article-title":"Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles","volume":"341","author":"Li","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2022.103393_b0180","doi-asserted-by":"crossref","first-page":"64103","DOI":"10.1088\/1748-605X\/ac2a8c","article-title":"Improved oral delivery of insulin by PLGA nanoparticles coated with 5beta-cholanic acid conjugated glycol chitosan","volume":"16","author":"Wang","year":"2021","journal-title":"Biomed Mater"},{"key":"10.1016\/j.drudis.2022.103393_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119516","article-title":"Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles","volume":"585","author":"Jaradat","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.08.005","article-title":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhance oral delivery of insulin","volume":"327","author":"Azevedo","year":"2020","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0195","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1039\/C9TB02860A","article-title":"Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems","volume":"8","author":"Bai","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.drudis.2022.103393_b0200","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.1021\/acsami.7b16524","article-title":"Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery","volume":"10","author":"Wu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.drudis.2022.103393_b0205","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2217\/nnm-2017-0372","article-title":"Targeted folate-conjugated pluronic P85\/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin","volume":"13","author":"Xie","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.drudis.2022.103393_b0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.msec.2017.04.113","article-title":"Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin","volume":"78","author":"Xu","year":"2017","journal-title":"Mat Sci Eng C-Mater"},{"key":"10.1016\/j.drudis.2022.103393_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.09.023","article-title":"The biology of mucus: composition, synthesis and organization","volume":"124","author":"Bansil","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2022.103393_b0220","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mi.2015.32","article-title":"New developments in goblet cell mucus secretion and function","volume":"8","author":"Birchenough","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.drudis.2022.103393_b0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2022.103393_b0230","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int J Pharmaceut"},{"issue":"12","key":"10.1016\/j.drudis.2022.103393_b0235","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0240","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2022.103393_b0245","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019Souza","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.drudis.2022.103393_b0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","article-title":"PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications","volume":"183","author":"Zhang","year":"2014","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0255","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u2018slip\u2019 through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew Chem Int Edit"},{"key":"10.1016\/j.drudis.2022.103393_b0260","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.actbio.2018.09.001","article-title":"PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils","volume":"79","author":"Kelley","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.drudis.2022.103393_b0265","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.drudis.2022.103393_b0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","article-title":"Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin","volume":"484","author":"Yu","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0275","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/adfm.201505000","article-title":"Sub-50 nm nanoparticles with biomimetic surfaces to sequentially overcome the mucosal diffusion barrier and the epithelial absorption barrier","volume":"26","author":"Zhu","year":"2016","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.drudis.2022.103393_b0280","article-title":"A core-shell insulin\/CS-PLGA nanoparticle for enhancement of oral insulin bioavailability: in vitro and in vivo study","author":"Wu","year":"2022","journal-title":"Int J Polym Mater Po"},{"key":"10.1016\/j.drudis.2022.103393_b0285","article-title":"The use of TPGS in drug delivery systems to overcome biological barriers","volume":"142","author":"Luiz","year":"2021","journal-title":"Eur Polym J"},{"key":"10.1016\/j.drudis.2022.103393_b0290","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2014.03.035","article-title":"Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy","volume":"72","author":"Jiang","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2022.103393_b0295","first-page":"2207","article-title":"Novel PLGA-based nanoparticles for the oral delivery of insulin","volume":"10","author":"Malathi","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2022.103393_b0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2022.103393_b0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(96)01600-8","article-title":"Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon","volume":"46","author":"Szentkuti","year":"1997","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0310","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2147\/IJN.S19491","article-title":"Doxorubicin-incorporated polymeric micelles composed of dextran-b- poly(DL-lactide-co-glycolide) copolymer","volume":"6","author":"Jeong","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2022.103393_b0315","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D1TB00806D","article-title":"Insulin- and cholic acid-loaded zein\/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin","volume":"9","author":"Bao","year":"2021","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.drudis.2022.103393_b0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2016.02.031","article-title":"Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation","volume":"227","author":"Alibolandi","year":"2016","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0325","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1039\/D0NR06104B","article-title":"Layer-by-layer coated nanoliposomes for oral delivery of insulin","volume":"13","author":"Zhang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.drudis.2022.103393_b0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2017.08.140","article-title":"Chitosan as biomaterial in drug delivery and tissue engineering","volume":"110","author":"Ahsan","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2022.103393_b0335","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijbiomac.2019.01.072","article-title":"Chitosan based-asymmetric membranes for wound healing: a review","volume":"127","author":"Miguel","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2022.103393_b0340","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2017.11.045","article-title":"Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery","volume":"535","author":"Baghdan","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2005.05.008","article-title":"Chitosan and the mucosal delivery of biotechnology drugs","volume":"2","author":"Issa","year":"2005","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.drudis.2022.103393_b0350","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejps.2012.01.002","article-title":"Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration","volume":"45","author":"Zhang","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0355","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijbiomac.2020.01.302","article-title":"Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin","volume":"149","author":"Kumari","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2022.103393_b0360","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijbiomac.2020.04.048","article-title":"Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection","volume":"156","author":"Leya","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2022.103393_b0365","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IJN.S252237","article-title":"Burgeoning polymer nano blends for improved controlled drug release: a review","volume":"15","author":"Maghsoudi","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2022.103393_b0370","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3390\/molecules24234371","article-title":"Glycol chitosan: a water-soluble polymer for cell imaging and drug delivery","volume":"24","author":"Lin","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.103393_b0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2017.11.020","article-title":"In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery","volume":"535","author":"Jafary Omid","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.carres.2016.08.002","article-title":"Recent research progress on preparation and application of N,N,N-trimethyl chitosan","volume":"434","author":"Wu","year":"2016","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.drudis.2022.103393_b0385","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.drudis.2022.103393_b0390","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2022.103393_b0395","doi-asserted-by":"crossref","first-page":"a029314","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.drudis.2022.103393_b0400","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.drudis.2016.04.007","article-title":"Intracellular transport of nanocarriers across the intestinal epithelium","volume":"21","author":"Fan","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2022.103393_b0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2022.103393_b0410","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12274-018-2264-9","article-title":"Glucose-responsive oral insulin delivery for postprandial glycemic regulation","volume":"12","author":"Yu","year":"2019","journal-title":"Nano Res"},{"key":"10.1016\/j.drudis.2022.103393_b0415","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41598-018-19170-y","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.103393_b0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-3659(99)00072-3","article-title":"Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents","volume":"60","author":"Anderson","year":"1999","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2022.103393_b0425","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-015-0714-3","article-title":"L-Valine appended PLGA nanoparticles for oral insulin delivery","volume":"52","author":"Jain","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.drudis.2022.103393_b0430","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/anie.201509183","article-title":"Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins","volume":"55","author":"Zhu","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.drudis.2022.103393_b0435","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3109\/10717544.2015.1058433","article-title":"A novel ligand conjugated nanoparticles for oral insulin delivery","volume":"23","author":"Liu","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.drudis.2022.103393_b0440","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.colsurfb.2015.01.035","article-title":"Surface engineered and ligand anchored nanobioconjugate: An effective therapeutic approach for oral insulin delivery in experimental diabetic rats","volume":"127","author":"Sharma","year":"2015","journal-title":"Colloid Surface B"},{"key":"10.1016\/j.drudis.2022.103393_b0445","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/D0BM01755H","article-title":"Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics","volume":"9","author":"Desale","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0450","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine enters cells more efficiently than other polycationic homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J Pept Res"},{"key":"10.1016\/j.drudis.2022.103393_b0455","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3109\/10717544.2015.1043472","article-title":"Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec)","volume":"23","author":"Zhu","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.drudis.2022.103393_b0460","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijpharm.2013.03.033","article-title":"Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin","volume":"448","author":"Liu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0465","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2022.103393_b0470","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/cr000700m","article-title":"Peroral route: an opportunity for protein and peptide drug delivery","volume":"101","author":"Sood","year":"2001","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2022.103393_b0475","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.drudis.2021.01.001","article-title":"Oral peptide delivery: challenges and the way ahead","volume":"26","author":"Dubey","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2022.103393_b0480","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1389203719666180517100339","article-title":"Influence of probiotics on dietary protein digestion and utilization in the gastrointestinal tract","volume":"20","author":"Wang","year":"2019","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0485","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.09.031","article-title":"Targeting of gastrointestinal tract for amended delivery of protein\/peptide therapeutics: strategies and industrial perspectives","volume":"196","author":"Pawar","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.drudis.2022.103393_b0490","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1023\/A:1015893832222","article-title":"Degradation of insulin by trypsin and alpha-chymotrypsin","volume":"8","author":"Schilling","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.drudis.2022.103393_b0495","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03639045.2018.1517776","article-title":"Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation - towards oral insulin delivery","volume":"45","author":"Ibie","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0500","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jbiotec.2020.04.016","article-title":"Insulin degrading enzyme (IDE) expressed by Chinese hamster ovary (CHO) cells is responsible for degradation of insulin in culture media","volume":"320","author":"Louie","year":"2020","journal-title":"J Biotechnol"},{"key":"10.1016\/j.drudis.2022.103393_b0505","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/cells10092445","article-title":"Insulin-degrading enzyme: paradoxes and possibilities","volume":"10","author":"Leissring","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2022.103393_b0510","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/ijms22052235","article-title":"Targeting insulin-degrading enzyme in insulin clearance","volume":"22","author":"Leissring","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0515","first-page":"S2","article-title":"Oral insulin delivery in diabetic rats by PLGA nanoparticles combined with a protease inhibitor (N-ethylmaleimide)","volume":"4","author":"Faheem","year":"2019","journal-title":"Br J Pharm"},{"key":"10.1016\/j.drudis.2022.103393_b0520","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1208\/s12249-019-1325-z","article-title":"Nanoparticles: oral delivery for protein and peptide drugs","volume":"20","author":"Cao","year":"2019","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.drudis.2022.103393_b0525","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.12.055","article-title":"HP55-coated capsule containing PLGA\/RS nanoparticles for oral delivery of insulin","volume":"425","author":"Wu","year":"2012","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.drudis.2022.103393_b0535","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ijms18010054","article-title":"Multifunctional composite microcapsules for oral delivery of insulin","volume":"18","author":"Sun","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2022.103393_b0540","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/1567201817666200512093639","article-title":"Expedition of Eudragit(R) polymers in the development of novel drug delivery systems","volume":"17","author":"Jain","year":"2020","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.drudis.2022.103393_b0545","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02652040801903843","article-title":"Improved bioavailability of orally delivered insulin using Eudragit-L30D coated PLGA microparticles","volume":"25","author":"Naha","year":"2008","journal-title":"J Microencapsul"},{"key":"10.1016\/j.drudis.2022.103393_b0550","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2147\/IJN.S81715","article-title":"pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin","volume":"10","author":"Sun","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2022.103393_b0555","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/02652040903515490","article-title":"Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation","volume":"27","author":"Sun","year":"2010","journal-title":"J Microencapsul"},{"key":"10.1016\/j.drudis.2022.103393_b0560","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110829","article-title":"Recent advances in the smart insulin delivery systems for the treatment of diabetes","volume":"161","author":"Lu","year":"2021","journal-title":"Eur Polym J"},{"key":"10.1016\/j.drudis.2022.103393_b0570","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2020.02.014","article-title":"Recent progress in design and preparation of glucose-responsive insulin delivery systems","volume":"321","author":"Shen","year":"2020","journal-title":"J Controll Release"},{"key":"10.1016\/j.drudis.2022.103393_b0575","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1039\/C6CC02202B","article-title":"Glucose-sensitive polymer nanoparticles for self-regulated drug delivery","volume":"52","author":"Zhao","year":"2016","journal-title":"Chem Commun"},{"key":"10.1016\/j.drudis.2022.103393_b0580","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1021\/acs.chemmater.7b01804","article-title":"Glucose-responsive nanosystem mimicking the physiological insulin secretion via an enzyme-polymer layer-by-layer coating strategy","volume":"29","author":"Xu","year":"2017","journal-title":"Chem Mater"},{"key":"10.1016\/j.drudis.2022.103393_b0585","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ijbiomac.2018.11.261","article-title":"Concanavalin A-sugar affinity based system: binding interactions, principle of glucose-responsiveness, and modulated insulin release for diabetes care","volume":"124","author":"Yin","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.drudis.2022.103393_b0590","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/IJN.S284357","article-title":"Bioresponsive functional phenylboronic acid-based delivery system as an emerging platform for diabetic therapy","volume":"16","author":"Ma","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.drudis.2022.103393_b0595","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.matt.2021.08.011","article-title":"Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes","volume":"4","author":"Xiao","year":"2021","journal-title":"Matter-Us"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622003865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622003865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:01:07Z","timestamp":1761224467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622003865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1359644622003865"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103393","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103393"}}